
Rockland Immunochemicals Advances Oligonucleotide Therapeutics with Novel Bioanalytical Technology
LIMERICK, PA — Rockland Immunochemicals, Inc., in collaboration with researchers from the Nucleic Acid Therapeutics Accelerator (NATA) in the United Kingdom, has co-authored a groundbreaking peer-reviewed article describing innovative bioanalytical approaches …
Rockland Immunochemicals Advances Oligonucleotide Therapeutics with Novel Bioanalytical Technology Read More